138 related articles for article (PubMed ID: 34277816)
1. Beta-1 syntrophin (SNTB1) regulates colorectal cancer progression and stemness via regulation of the Wnt/β-catenin signaling pathway.
Liang Y; Wang B; Chen S; Ye Z; Chai X; Li R; Li X; Kong G; Li Y; Zhang X; Che Z; Xie Q; Lian J; Lin B; Zhang X; Huang X; Huang W; Qiu X; Zeng J
Ann Transl Med; 2021 Jun; 9(12):1016. PubMed ID: 34277816
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer.
Liu L; Chen Y; Lin X; Wu M; Li J; Xie Q; Sferra TJ; Han Y; Liu H; Cao L; Yao M; Peng J; Shen A
Cancer Cell Int; 2021 Oct; 21(1):547. PubMed ID: 34663329
[TBL] [Abstract][Full Text] [Related]
3. SNTB1 regulates colorectal cancer cell proliferation and metastasis through YAP1 and the WNT/β-catenin pathway.
Zhang H; Li Z; Jiang J; Lei Y; Xie J; Liu Y; Yi B
Cell Cycle; 2023 Sep; 22(17):1865-1883. PubMed ID: 37592763
[TBL] [Abstract][Full Text] [Related]
4. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
[TBL] [Abstract][Full Text] [Related]
6. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
8. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
[TBL] [Abstract][Full Text] [Related]
9. FOXQ1-mediated SIRT1 upregulation enhances stemness and radio-resistance of colorectal cancer cells and restores intestinal microbiota function by promoting β-catenin nuclear translocation.
Yang M; Liu Q; Dai M; Peng R; Li X; Zuo W; Gou J; Zhou F; Yu S; Liu H; Huang M
J Exp Clin Cancer Res; 2022 Feb; 41(1):70. PubMed ID: 35183223
[TBL] [Abstract][Full Text] [Related]
10. Sestrin2 reduces cancer stemness via Wnt/β-catenin signaling in colorectal cancer.
Wei J; Zheng X; Li W; Li X; Fu Z
Cancer Cell Int; 2022 Feb; 22(1):75. PubMed ID: 35148781
[TBL] [Abstract][Full Text] [Related]
11. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
12. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
[TBL] [Abstract][Full Text] [Related]
13. EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β-catenin pathway.
Zhang QW; Zhang XT; Tang CT; Lin XL; Ge ZZ; Li XB
Mol Carcinog; 2019 Jun; 58(6):967-979. PubMed ID: 30693973
[TBL] [Abstract][Full Text] [Related]
14. TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways.
Yang RW; Zeng YY; Wei WT; Cui YM; Sun HY; Cai YL; Nian XX; Hu YT; Quan YP; Jiang SL; Wang M; Zhao YL; Qiu JF; Li MX; Zhang JH; He MR; Liang L; Ding YQ; Liao WT
J Exp Clin Cancer Res; 2016 Sep; 35(1):152. PubMed ID: 27669982
[TBL] [Abstract][Full Text] [Related]
15. UBQLN4 is activated by C/EBPβ and exerts oncogenic effects on colorectal cancer via the Wnt/β-catenin signaling pathway.
Tang X; Liang Y; Sun G; He Q; Qu H; Gao P
Cell Death Discov; 2021 Dec; 7(1):398. PubMed ID: 34930912
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS12 acts as a cancer promoter in colorectal cancer via activating the Wnt/β-catenin signaling pathway
Li C; Luo X; Huang B; Wang X; Deng Y; Zhong Z
Ann Transl Med; 2020 Mar; 8(6):301. PubMed ID: 32355745
[TBL] [Abstract][Full Text] [Related]
17. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway.
Xiao Z; Qu Z; Chen Z; Fang Z; Zhou K; Huang Z; Guo X; Zhang Y
Cell Physiol Biochem; 2018; 46(3):1275-1285. PubMed ID: 29680837
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
[TBL] [Abstract][Full Text] [Related]
20. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
